Can 3D Laparoscopy Improve Surgical Performances in Surgeons in Training?

Status Recruiting

Clinical Trial Summary

Due to the inconclusive results on the benefits of 3D laparoscopic system present in literature, this prospective randomised pilot study aims to assess if the operative time of total laparoscopic hysterectomy (TLH) for benign indication performed by trainees could be reduced using 3D laparoscopy instead of standard laparoscopy.

Clinical Trial Description

All patients with benign uterine pathology at preoperative examinations (pelvic ultrasound and/or magnetic resonance and/or CT scan) and with indication for total laparoscopic hysterectomy, will be enrolled in the study.

While under general anesthesia, the patient is positioned in the dorsal lithotomic position with both legs supported in stirrups with a Trendelenburg tilt and arms along the body. A four disposable or reusable, sterile trocar transperitoneal approach is used. A 10 mm port is inserted at the umbilicus for the telescope. Once pneumoperitoneum (12 mmHg) is achieved, intra-abdominal visualization will be obtained with a 0° high-definition telescope (HD EndoEye 10 mm, Olympus Winter & IBE GMBH, Hamburg - Germany) or with 0° 3D laparoscopy high-definition (Olympus Winter & IBE GMBH, Hamburg - Germany). The instruments used include bipolar grasper, monopolar scissors, monopolar hook, various graspers and a suction irrigation system. Clermont Ferrand uterine manipulator (Model K.Storz Endoskope,Tuttlingen, Germany) is optionally used to move the uterus.

Total hysterectomy is then performed according to standard technique used by the recruiting center (development of the pararectal space and identification of uterine artery, coagulation of ovarian pedicles, development of the vesico-uterine septum, colpotomy).The vaginal vault is then closed with a 0 Vycril suture laparoscopically (continuous suture).

Detailed operative time, intra and post operative early complications will be recorded (Extended Clavien‑Dindo classification of surgical complications will be used for post operative complications) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04209036
Study type	Observational
Source	Catholic University of the Sacred Heart
Contact	Francesco Fanfani, Professor
Phone	06 30154979
Email	francesco.fanfani74@gmail.com
Status	Recruiting
Phase
Start date	November 1, 2019
Completion date	December 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04073485` - Microwave Ablation for Uterine Fibroids	N/A
Recruiting	`NCT04519593` - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma	N/A
Recruiting	`NCT01239641` - High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids	Phase 4
Recruiting	`NCT04748978` - OPPIuM Technique and Myolysis With Diode Laser Dwls	N/A
Not yet recruiting	`NCT04191603` - TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY	N/A
Terminated	`NCT04132349` - Ulipristal Acetate in Symptomatic Uterine Fibroid	Phase 4
Completed	`NCT03412890` - LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Completed	`NCT03021720` - Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial	N/A
Completed	`NCT05086770` - Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere	N/A
Recruiting	`NCT05416424` - Life Study: Lifestyle Intervention in Fibroid Elimination	N/A
Not yet recruiting	`NCT05695690` - Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification
Enrolling by invitation	`NCT06430320` - Ascertaining Longterm Outcomes of Fibroid Treatments
Completed	`NCT04832906` - UA Versus UAE in Treatment of Fibroids	Phase 4
Completed	`NCT03444987` - The Role of Fibroblast Activation in Uterine Fibroid
Active, not recruiting	`NCT06244251` - Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids	N/A
Not yet recruiting	`NCT06153667` - Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
Not yet recruiting	`NCT03450421` - Safety and Efficacy of Actamax™Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy	N/A
Not yet recruiting	`NCT05840042` - Epidemiology and Risk Factors of Uterine Fibroids in China
Completed	`NCT04345003` - MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids	N/A
Recruiting	`NCT03118037` - Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.